Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,337–3,344 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
PLUS THERAPEUTICS Inc. REYOBIQ (rhenium Re186 obisbemeda) - (ReSPECT-GBM) Glioma Phase 2 Ongoing Intracerebral Oncology
PLUS THERAPEUTICS Inc. DocePLUS (ATI-1123) Platinum-sensitive small cell lung cancer Phase 2 Intravenous Oncology
PMGC Holdings Inc. Exosomes Hairloss Phase 2 Data Released Intravenous N/A
PMGC Holdings Inc. EL-22 (BLS-M22) GLP-1 Weight Loss Drugs and Age-Related Sarcopenia Phase 2 Trial Planned Intravenous Endocrinology
PMV Pharmaceuticals Inc. Rezatapopt (PC14586) - (PYNNACLE) Solid tumors NDA Filing Ongoing oral Oncology
PolyPid Ltd. D-PLEX100 - (SHIELD II) Surgical Site Infection NDA Filing Data Released Intraperitoneal Wound Care
PolyPid Ltd. D-PLEX100 Sternal (bone) sternal surgical site infections Phase 3 Clinical Pause Intratumoral Wound Care
PolyPid Ltd. D-PLEX100 - (SHIELD I) Abdominal (soft tissue) sternal surgical site infections Phase 3 Data Released Intraperitoneal Wound Care